Endogenous hypoxia-inducible factor 1α antisense RNA2 (lncRNA HIF1A-AS2) is involved the development and progression of bladder cancer, glioblastoma, breast cancer, and osteosarcoma [48]. This evidence concerns the gene HIF1A and breast cancer.